← Back to Insights
CDMOGxPDigital MaturityCell & Gene Therapy

Assessing Digital Maturity in Regulated CDMOs: Where to Start

Cell and gene therapy CDMOs face a unique digital maturity challenge: they must move fast to scale manufacturing while maintaining GxP compliance at every step. Here’s how we approach the assessment.

KM
Kees Mensch
Partner · December 2025 · 7 min read
In This Article
Article Content
Frameworks Referenced
CDMOGxPDigital MaturityCell & Gene Therapy

Article Content

KM
Kees Mensch
Partner at The Digital Capability Company

Partner at The Digital Capability Company, driving digital transformation for regulated industries.

Related Articles

All insights →

Want to discuss this topic?

We're practitioners, not sales people. Reach out for a direct conversation about your specific situation.

Schedule a conversation